Euro-BioImaging ERIC

Euro-BioImaging ERIC is a European research infrastructure consortium (ERIC) that offers open access to state-of-the-art imaging technologies, training, and data services in biological and biomedical imaging.

Through Euro-BioImaging, life science researchers will receive help planning imaging projects, assistance in implementing advanced biomedical imaging applications, and advice on what kind of cutting-edge imaging instruments would be best suited for a particular purpose and research project. The services also include expertise related to special methods and techniques, ample training opportunities for both users and service providers, and unique data analysis and data management services.

All scientists, regardless of their affiliation, area of expertise, or field of activity can benefit from these pan-European open access services, which are provided with high quality standards by leading imaging facilities.

The Euro-BioImaging mission:

– Open access across country borders to top-notch biological and biomedical imaging facilities offering their technologies and services

– Open access to advanced training, and support, that ensures correct and productive use of the technologies to maximise the output of the research projects. Guidance is available for all aspects of the imaging pipeline, from study design to image capture.

– Open access to computational services for handling and quantitative analysis of the large amounts of digital imaging data produced.

Imaging technologies are the central technology platform driving research in life sciences. Euro-BioImaging contributes to discoveries in health, food security, plant biology, marine ecosystems, the environment, and beyond. Euro-BioImaging promotes FAIR image data, enabling cross-disciplinary research via integration with other data types.

Euro-BioImaging ERIC is a joint effort of 16 member countries, the international organization EMBL. Euro-BioImaging ERIC is managed by the tripartite Hub, that consists of Finland as the statutory seat, EMBL as the biological imaging coordinator (Bio-Hub) and host of general data services, and Italy as the biomedical imaging coordinator (Med-Hub).

Euro-BioImaging services are provided by 35 Nodes (comprising over 173 renowned imaging facilities), that are distributed across Europe. These services can be accessed by all scientists in need of imaging technologies through the Euro-BioImaging Web Portal

Euro-BioImaging is a strong partner in cross-RI projects, such as the successfully concluded cluster project CORBEL and the ongoing EOSC-Life cluster project. Thereby, Euro-BioImaging enabled cross-cutting interdisciplinary projects, which allowed the users to advance in their research and to open new avenues in science. EOSC-Life started in March 2019, connecting the 13 ESFRI research infrastructures in the Health and Food domain to create an open collaborative digital space for life science in the European Open Science Cloud.

Euro-BioImaging also has strong international connections with imaging communities and infrastructures around the world, via the Global BioImaging network ( In fact, Euro-BioImaging is a founding partner of Global BioImaging, which also comprises partners in Africa, Australia, India, Japan, Singapore and North & South America. Via this network, Euro-BioImaging contributes to shaping the international discussion on the key role that Research Infrastructures and imaging technologies play in advancing the Life Sciences and leads capacity building efforts in science globally.

Role of institution in the project

Euro-BioImaging ERIC is actively involved in WP2 (Task 2.1), WP5 (Task 5.5), WP7 leading Task 7.1 and WP8 (WP-Leader), by contributing to the identification of health data providers, preparation of open calls for data incorporation use cases and contributing to the definition of the long-term maintenance and expansion of the platform.

Dr. Alessandra Viale

Dr. Alessandra Viale is a scientific project manager at the Euro-BioImaging Med-Hub. She has a background in chemistry and previous experience as a researcher in the MR probe development field. She moved to Euro-BioImaging in 2016, actively collaborating to the construction of the Infrastructure and to the start of its operational phase. Currently she is committed to the management of user access, coordination of the Euro-BioImaging Nodes and project management in the field of preclinical and human imaging.

Dr Aastha Mathur

Dr Aastha Mathur is the Coordinator of Image Data Services at Euro-BioImaging ERIC. Having a background in bioinformatics, imaging and image analysis, she is currently representing Euro-BioImaging and imaging community at the EOSC-Association, and multiple EOSC related projects, like EOSC-future and By-Covid, as well as coordinating provision of Image Data Analysis Services through Euro-BioImaging Nodes.

Dr. Susanne Vainio

Dr. Susanne Vainio is a Scientific officer at Euro-Bioimaging responsible for quality management of medical imaging, Horizon Europe project management, as well as equality work and administrative tasks of the organization. I obtained my PhD in Clinical Neurosciences from the Turku PET Centre. My research expertise is in preclinical PET- and autoradiography imaging of neuroinflammation and multiple sclerosis; establishing experimental neuroinflammatory models; neuroimmunology; immunohistochemistry; and image processing & analysis.

Dr. John E. Eriksson

Dr. John E. Eriksson is a Professor of Cell Biology and Director of Euro-BioImaging ERIC (, the pan-European organization of advanced biological and biomedical imaging, with Headquarters in Turku, Finland. Beyond making Euro-BioImaging the leading gateway to European imaging excellence, one of his pronounced ambitions, is also to generate a continuum from advanced imaging of diseases states with big data from omics and biobanks using the vast imaging resources of Euro-BioImaging and active collaboration with other major European and global life science research infrastructure and data-related organizations. By combining advanced imaging technologies with other cutting-edge molecular technologies, his research team has unraveled a selection of cellular signaling networks that determine critical cell responses for human health, including activation of survival mechanisms, cell growth, differentiation, and cell migration. Some of the findings have also led to innovations in both drug development and biomaterial sciences that have resulted in a number of international patents including a recent start-up company. He has published more than 200 scientific articles, numerous patents, and is an elected member of the Finnish Society of Sciences and the Technical Science Academy of Finland.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

March 14, 10:00-11:30 aM CET



Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.